Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

78,757.40

Todday's Low

78,377.07

Open at

78,516.08

Previous Close

78,954.76

Volumes

Avg Price

-455.59

Historical Performance

News

01 Aug 26
Dr. Reddy’s rituximab biosimilar approved in the U.S., commercialized by Fresenius Kabi
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced that the U.
23 Jul 26
Dr Reddys Labs slides after Q1 PAT plunges 69% YoY to Rs 444 crore
Revenue from operations declined 5.55% YoY to Rs 8,070.5 crore in the quarter ended 30 June 2026.
22 Jul 26
Dr Reddy's Labs Q1 PAT plunges 69% YoY to Rs 444 crore
Revenue from operations declined 5.55% YoY to Rs 8,070.5 crore in the quarter ended 30 June 2026.
22 Jul 26
Dr Reddy's Laboratories consolidated net profit declines 68.67% in the June 2026 quarter
Net profit of Dr Reddy's Laboratories declined 68.67% to Rs 444.30 crore in the quarter ended June 2026 as against Rs 1418.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
06-08-26 1174.00 1174.40 1163.00 1171.00 1329196 49819 1555276271.40 24636.00
05-08-26 1171.80 1178.40 1157.70 1176.00 1883679 70836 2208773066.80 24624.65
04-08-26 1174.00 1174.00 1154.40 1172.60 2165315 57579 2515984205.20 24614.90
03-08-26 1166.20 1182.00 1160.30 1180.00 2150927 89061 2509924768.90 24774.30
31-07-26 1152.00 1154.30 1141.70 1148.10 1085841 43549 1247474999.60 24383.60
30-07-26 1143.00 1151.00 1139.00 1144.80 1350714 51899 1544261373.60 24317.15
29-07-26 1144.00 1147.80 1131.10 1142.30 1280586 49186 1460275800.60 24250.20
28-07-26 1145.00 1149.00 1130.20 1135.60 2157306 77325 2453674273.80 23985.35
27-07-26 1154.70 1159.30 1147.20 1150.80 1053461 47835 1213534140.00 23995.95
24-07-26 1147.00 1166.30 1131.40 1151.70 4750512 123522 5447881953.70 23767.45

Fundamentals

Company Valuation

Market Cap (₹cr)

98074.41

PE Ratio

147.8

PB Ratio

3.11

Dividend Yield

0.68

ROE

10.69

ROCE

12.59

Book Value (₹)

377.9559391

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50589900 6.06 50589900 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 171726540 20.57 171726540 2
Others 0 0.00 0 0
Sub Total 222316440 26.64 222316440 11
Total ShareHolding for Promoter & Group 222316440 26.64 222316440 11
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 720713 0.09 719963 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 172474302 20.66 172474302 721
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 95244276 11.41 95244276 1
Insurance Companies 127186273 15.24 127186273 32
Mutual Funds / UTI 109815586 13.16 109815136 40
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 27180250 3.26 27180250 26
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 532621400 63.81 532620200 827
plus  Non Institution
Bodies Corporate 2883453 0.35 2872953 1320
Clearing Members 1581850 0.19 1581850 61
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7633935 0.91 7304455 13866
Foreign Non Institution Other 129462 0.02 129462 3
Hindu Undivided Families 1257062 0.15 1257062 4008
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 659200 0.08 659200 2
Individuals holding nominal share capital up to Rs. 1 lakh 61288983 7.34 60375013 425965
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 28516 0.00 28516 19
Others 2446869 0.29 2446869 2
Sub Total 78046300 9.35 76792350 445247
Total Public Shareholding 610667700 73.16 609412550 446074
Total of Promoter & Public ShareHolding 832984140 99.80 831728990 446085
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 1691660 0.20 1691660 1
Total Shares held by Custodians and against which Depository Receipts have been issued 1691660 0.20 1691660 1
Grand Total 834675800 100.00 833420650 446086

Financials (₹ in cr)

Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales33,700.2032,643.9028,011.1024,669.7021,545.20
OPM (%)16.0023.5325.7124.5214.21
OP5,392.707,679.507,201.006,048.503,061.40
Other Income1,358.401,097.30894.301,055.50484.40
PBIDT7,825.309,666.108,842.107,441.504,322.40
INTEREST373.80282.90171.10142.8095.80
PBDT7,451.509,383.208,671.007,298.704,226.60
PBT5,392.707,679.507,201.006,048.503,061.40
EO0.000.000.000.000.00
PBT after EO5,392.707,679.507,201.006,048.503,061.40
TAXES1,235.101,954.301,623.101,541.20878.90
PAT4,196.005,655.105,577.904,507.302,182.50
EPS50.3567.7966.92270.90131.21
Raw Material19.2917.4116.0317.1120.02
Power and Fuel1.651.721.911.941.81
Employee Cost17.7817.0917.9618.8418.04
Other Manufacturing Expenses1.782.362.081.952.86
Selling and Administration Expenses15.5814.5113.2512.9713.81
Miscellaneous Expenses2.872.071.812.446.87
Revenue (Growth %) 3.2416.5413.5414.5013.11
PBIDT (Growth %)-19.049.3218.8272.162.69
PAT (Growth %) -25.801.3823.75106.5211.83
PBIDT (Margin %)23.2229.6131.5730.1620.06
PAT (Margin %) 12.4517.3219.9118.2710.13

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 83.5083.4083.4083.3083.2083.20
Reserves Total 31463.6028999.6024157.4020517.8018413.1017097.20
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money-181.50-226.400.00-126.90-160.10-196.70
Total Shareholders Funds31365.6028856.6024240.8020474.2018336.2016983.70
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 5737.003492.90792.9050.802205.401214.50
Total Debt5737.003492.90792.9050.802205.401214.50
Other Liabilities254.00190.60114.8093.1094.6067.90
Total Liabilities37356.6032540.1025148.5020618.1020636.2018266.10
APPLICATION OF FUNDS :
Gross Block 21344.4017714.8016297.2015136.6013349.1012345.00
Less : Accumulated Depreciation 10614.309482.408708.107941.307198.606500.70
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 10730.108232.407589.107195.306150.505844.30
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress1369.102196.801211.00924.401200.30900.80
Producing Properties0.000.000.000.000.000.00
Investments 15594.8013193.507320.607440.004936.704649.20
Current Assets, Loans & Advances
Inventories 4955.604575.804018.903043.003347.802819.70
Sundry Debtors 4118.605959.004623.904288.904945.404080.00
Cash and Bank Balance1957.60976.801216.90645.802030.501646.50
Loans and Advances 4257.902108.403838.301512.801255.201141.00
Total Current Assets15289.7013620.0013698.009490.5011578.909687.20
Less : Current Liabilities and Provisions
Current Liabilities 5241.504816.504399.404112.303537.203064.80
Provisions 414.10418.90395.30305.20322.20298.70
Total Current Liabilities & Provisions5655.605235.404794.704417.503859.403363.50
Net Current Assets9634.108384.608903.305073.007719.506323.70
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets196.9094.5095.100.00441.60582.10
Deferred Tax Liability786.80609.90511.20339.20422.20327.30
Net Deferred Tax-589.90-515.40-416.10-339.2019.40254.80
Other Assets618.401048.20540.60324.60609.80293.30
Total Assets37356.6032540.1025148.5020618.1020636.2018266.10
Contingent Liabilities0.000.000.000.000.000.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 505.50-2,696.9068.101,590.701,116.80
Investing Activities -1,990.10-3,403.20-3,428.70-5,697.40-5,759.50
Net Cash Flow -145.90-1,047.2089.10118.3017.80
Operating Activities 1,338.705,052.903,449.704,225.004,660.50

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SR
Satish Reddy
Chairman & Exec. Director
Executive
GVP
G V Prasad
Co-Chairman & Managing Director
Executive
Independent Directors
LP
Leo Puri
Independent Non Exe. Director
Ind.
SS
Shikha Sharma
Independent Non Exe. Director
Ind.
KPK
KODUMUDI PRANATHARTHIHARAN KRISHNAN
Independent Non Exe. Director
Ind.
PW
Pennv Wan
Independent Non Exe. Director
Ind.
AMK
Arun M. Kumar
Independent Non Exe. Director
Ind.
CA
Claudio Albrecht
Independent Non Exe. Director
Ind.
AHS
ALPNA HANSRAJ SETH
Independent Non Exe. Director
Ind.
SM
Sanjiv Mehta
Independent Non Exe. Director
Ind.
SRV
Srikanth Ramakrishna Velamakanni
Independent Non Exe. Director
Ind.
Other Officials
KRS
K Randhir Singh
CS / CO / Head - CSR
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Dr Reddys Laboratories Ltd?

Dr Reddys Laboratories Ltd trades on NSE under DRREDDY and on BSE under code 500124. The ISIN is INE089A01031 and the face value is Rs 1.

What is the share price of Dr Reddys Laboratories Ltd today? +

As of 07 August 2026, Dr Reddys Laboratories Ltd trades at Rs 1,172.00, a change of 1.00 (0.09%) on the day. Prices are live and subject to change.

What is the market capitalisation of Dr Reddys Laboratories Ltd? +

As of 07 August 2026, Dr Reddys Laboratories Ltd has a market cap of about Rs 98074.41 crore. This figure is live and moves with the share price.

Is Dr Reddys Laboratories Ltd profitable? +

In March 2026, Dr Reddys Laboratories Ltd reported a profit after tax of Rs 4,196.00 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Dr Reddys Laboratories Ltd? +

: As of 07 August 2026, the PE (TTM) for Dr Reddys Laboratories Ltd is 147.8 and the price-to-book ratio is 3.11. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Dr Reddys Laboratories Ltd pay a dividend? +

As of 07 August 2026, the dividend yield for Dr Reddys Laboratories Ltd is 0.68%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Dr Reddys Laboratories Ltd? +

As of the latest disclosed pattern, promoters hold 26.64% of Dr Reddys Laboratories Ltd. Public shareholding is 73.16%, including mutual funds at 13.16% and foreign institutional investors at 20.66%.

What were the latest annual financials of Dr Reddys Laboratories Ltd? +

In March 2026, Dr Reddys Laboratories Ltd reported net sales of Rs 33,700.20 crore, revenue growth of 3.24%, and earnings per share of Rs 50.35.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web